Singapore markets open in 4 hours 55 minutes
Straits Times Index
3,306.02 +6.02 (+0.18%) S&P 500
5,464.62 -8.55 (-0.16%) Dow
39,150.33 +15.53 (+0.04%) Nasdaq
17,689.36 -32.24 (-0.18%) Bitcoin USD
64,109.28 -157.25 (-0.24%) CMC Crypto 200
1,321.45 -38.88 (-2.86%)
Beximco Pharmaceuticals Limited (R2WA.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
At close: 10:55AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 369.64M |
| Enterprise value | 417.20M |
| Trailing P/E | 4.77 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.59 |
| Price/book (mrq) | 0.55 |
| Enterprise value/revenue | 1.24 |
| Enterprise value/EBITDA | 6.60 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.63 |
| 52-week change 3 | 15.54% |
| S&P500 52-week change 3 | 26.24% |
| 52-week high 3 | 0.5000 |
| 52-week low 3 | 0.3700 |
| 50-day moving average 3 | 0.4220 |
| 200-day moving average 3 | 0.4330 |
Share statistics
| Avg vol (3-month) 3 | 440 |
| Avg vol (10-day) 3 | 100 |
| Shares outstanding 5 | 446.11M |
| Implied shares outstanding 6 | 467.19M |
| Float 8 | 297.32M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 1.72% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.03 |
| Forward annual dividend yield 4 | 6.61% |
| Trailing annual dividend rate 3 | 3.50 |
| Trailing annual dividend yield 3 | 784.75% |
| 5-year average dividend yield 4 | 4.13 |
| Payout ratio 4 | 29.75% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 10 Nov 2023 |
| Last split factor 2 | 1.1:1 |
| Last split date 3 | 23 Nov 2020 |
Financial highlights
Currency in BDT.Fiscal year
| Fiscal year ends | 30 Jun 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 12.37% |
| Operating margin (ttm) | 17.20% |
Management effectiveness
| Return on assets (ttm) | 6.97% |
| Return on equity (ttm) | 10.99% |
Income statement
| Revenue (ttm) | 43.08B |
| Revenue per share (ttm) | 96.58 |
| Quarterly revenue growth (yoy) | 15.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 9.44B |
| Net income avi to common (ttm) | 5.33B |
| Diluted EPS (ttm) | 0.0900 |
| Quarterly earnings growth (yoy) | 43.50% |
Balance sheet
| Total cash (mrq) | 1.73B |
| Total cash per share (mrq) | 3.88 |
| Total debt (mrq) | 7.43B |
| Total debt/equity (mrq) | 14.73% |
| Current ratio (mrq) | 1.80 |
| Book value per share (mrq) | N/A |
Cash flow statement
| Operating cash flow (ttm) | 8.37B |
| Levered free cash flow (ttm) | 4.42B |
© 2024 Yahoo. All rights reserved.